Back to all Programs

Register here

Related Materials

Past event

Leveraging mRNA Technology Workshop - 1st Edition

Advances in Nucleic Acid Vaccine Technology | Anna Blakney

Opening Lecture on mRNA Technology: Historical Perspective | Elie Dolgin

Polyvalent Vaccines | James Brien

Safety Profiles of COVID-19 Vaccines | John R. Su

RNA Vaccine Platforms: Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors | Karine Breckpot

Clinical Update on mRNA Vaccines for Flu | M. Anthony Moody

Development of Universal Influenza Vaccines Using Nucleoside-Modified mRNA | Norbert Pardi

Vaccines for Respiratory Syncytial Virus | Tracy Ruckwardt

Scientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy | Matthew Gagne